Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.230 MYR | -2.12% |
|
-5.00% | -37.52% |
06-23 | PETRONAS Chemicals Group Berhad, Q4 2024 Earnings Call, Feb 21, 2025 | |
05-21 | Malaysian Shares Post Five-Day Rout | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.49 | 10.14 | 8.14 | 2.33 | 2.14 | |||||
Return on Total Capital | 4.09 | 11.91 | 9.93 | 2.95 | 2.78 | |||||
Return On Equity % | 5.15 | 22 | 16.85 | 4.28 | 3.14 | |||||
Return on Common Equity | 5.39 | 22.44 | 17.1 | 4.27 | 2.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.54 | 37.26 | 29.97 | 16.69 | 15.34 | |||||
SG&A Margin | 11.73 | 8.38 | 8.96 | 11.51 | 11.97 | |||||
EBITDA Margin % | 26.25 | 37.1 | 28.1 | 13.83 | 13.51 | |||||
EBITA Margin % | 15.55 | 30.56 | 23.16 | 8.12 | 7.29 | |||||
EBIT Margin % | 15.32 | 30.45 | 22.91 | 7.52 | 6.71 | |||||
Income From Continuing Operations Margin % | 11.04 | 31.79 | 21.85 | 6.1 | 4.2 | |||||
Net Income Margin % | 11.34 | 31.9 | 21.84 | 5.92 | 3.83 | |||||
Net Avail. For Common Margin % | 11.34 | 31.9 | 21.84 | 5.92 | 3.83 | |||||
Normalized Net Income Margin | 8.37 | 21.04 | 14.52 | 4.41 | 3.07 | |||||
Levered Free Cash Flow Margin | 9.17 | 21.36 | 11.21 | 8.64 | 5.91 | |||||
Unlevered Free Cash Flow Margin | 9.25 | 21.41 | 11.26 | 8.74 | 6.25 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.53 | 0.57 | 0.5 | 0.51 | |||||
Fixed Assets Turnover | 0.7 | 1.07 | 1.18 | 1.02 | 1.05 | |||||
Receivables Turnover (Average Receivables) | 8.44 | 11.14 | 10.39 | 10.04 | 10.35 | |||||
Inventory Turnover (Average Inventory) | 6.26 | 7.19 | 7.14 | 6.6 | 6.61 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.09 | 4.33 | 2.46 | 1.89 | 1.68 | |||||
Quick Ratio | 4.53 | 3.88 | 1.93 | 1.47 | 1.31 | |||||
Operating Cash Flow to Current Liabilities | 0.93 | 1.65 | 1.24 | 0.57 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 43.36 | 32.77 | 35.13 | 36.34 | 35.35 | |||||
Days Outstanding Inventory (Average Inventory) | 58.49 | 50.78 | 51.11 | 55.27 | 55.35 | |||||
Average Days Payable Outstanding | 30.1 | 32.27 | 36.03 | 33.87 | 74.53 | |||||
Cash Conversion Cycle (Average Days) | 71.75 | 51.27 | 50.21 | 57.74 | 16.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 10.26 | 10.83 | 11.4 | 12.2 | 13.29 | |||||
Total Debt / Total Capital | 9.3 | 9.77 | 10.24 | 10.87 | 11.73 | |||||
LT Debt/Equity | 9.36 | 9.97 | 10.51 | 10.46 | 10.74 | |||||
Long-Term Debt / Total Capital | 8.49 | 9 | 9.44 | 9.33 | 9.48 | |||||
Total Liabilities / Total Assets | 22.14 | 23.75 | 28.32 | 30.12 | 33.39 | |||||
EBIT / Interest Expense | 129.41 | 412.35 | 276.42 | 49 | 12.54 | |||||
EBITDA / Interest Expense | 227.65 | 509.41 | 342.62 | 93.95 | 26.49 | |||||
(EBITDA - Capex) / Interest Expense | 140.82 | 418.94 | 264.25 | 40.5 | 11.54 | |||||
Total Debt / EBITDA | 0.82 | 0.44 | 0.55 | 1.24 | 1.22 | |||||
Net Debt / EBITDA | -2.46 | -1.45 | -0.53 | -1 | -1.06 | |||||
Total Debt / (EBITDA - Capex) | 1.33 | 0.54 | 0.71 | 2.88 | 2.81 | |||||
Net Debt / (EBITDA - Capex) | -3.98 | -1.76 | -0.69 | -2.32 | -2.44 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -12.27 | 60.32 | 25.74 | -0.99 | 6.99 | |||||
Gross Profit, 1 Yr. Growth % | -20.89 | 143.35 | 1.13 | -44.85 | -1.65 | |||||
EBITDA, 1 Yr. Growth % | -21.47 | 126.58 | -5.07 | -51.26 | 4.49 | |||||
EBITA, 1 Yr. Growth % | -31.08 | 215.14 | -4.74 | -65.28 | -3.95 | |||||
EBIT, 1 Yr. Growth % | -32.1 | 218.64 | -5.38 | -67.5 | -4.59 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -43.26 | 361.48 | -13.57 | -72.34 | -26.34 | |||||
Net Income, 1 Yr. Growth % | -42.08 | 351.17 | -13.94 | -73.17 | -30.72 | |||||
Normalized Net Income, 1 Yr. Growth % | -39.5 | 302.85 | -13.26 | -69.91 | -25.5 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -42.08 | 351.17 | -13.94 | -73.17 | -30.72 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.96 | 53.46 | 22.65 | -14.07 | 24.6 | |||||
Inventory, 1 Yr. Growth % | 8.93 | 22.59 | 56.5 | 8.72 | 8.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.46 | 5.68 | 23.23 | 8.24 | -0.33 | |||||
Total Assets, 1 Yr. Growth % | 2.49 | 17.02 | 19.32 | 8.62 | -0.31 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.19 | 15.53 | -13.3 | 1.53 | -1.67 | |||||
Common Equity, 1 Yr. Growth % | 1.71 | 14.97 | 12.13 | 3.42 | -4.6 | |||||
Cash From Operations, 1 Yr. Growth % | -45.62 | 171.48 | -1.67 | -36.4 | -9.63 | |||||
Capital Expenditures, 1 Yr. Growth % | -37.22 | 4.2 | 22.22 | 25.04 | 4.25 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -36.44 | 273.37 | -34.02 | -23.64 | -26.83 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -36.28 | 271.18 | -33.85 | -23.15 | -23.54 | |||||
Dividend Per Share, 1 Yr. Growth % | -33.33 | 283.33 | -10.87 | -68.29 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -14.35 | 18.6 | 41.98 | 11.58 | 2.92 | |||||
Gross Profit, 2 Yr. CAGR % | -28.39 | 38.75 | 56.88 | -25.32 | -26.35 | |||||
EBITDA, 2 Yr. CAGR % | -28.83 | 33.39 | 46.91 | -31.98 | -28.64 | |||||
EBITA, 2 Yr. CAGR % | -38.09 | 47.37 | 73.28 | -42.49 | -42.25 | |||||
EBIT, 2 Yr. CAGR % | -38.54 | 47.09 | 73.65 | -44.55 | -44.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -42.96 | 61.82 | 99.73 | -51.11 | -54.86 | |||||
Net Income, 2 Yr. CAGR % | -41.69 | 61.65 | 97.06 | -51.95 | -56.89 | |||||
Normalized Net Income, 2 Yr. CAGR % | -42.29 | 56.11 | 86.95 | -48.91 | -52.65 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -41.69 | 61.65 | 97.06 | -51.95 | -56.89 | |||||
Accounts Receivable, 2 Yr. CAGR % | -11.83 | 18.85 | 37.2 | 2.66 | 3.47 | |||||
Inventory, 2 Yr. CAGR % | 3.13 | 15.56 | 38.51 | 30.44 | 8.59 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.89 | 4.06 | 13.72 | 15.49 | 3.87 | |||||
Total Assets, 2 Yr. CAGR % | 3.24 | 9.51 | 17.97 | 13.84 | 4.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 0.23 | 8.12 | -0.15 | -6.18 | -0.08 | |||||
Common Equity, 2 Yr. CAGR % | 1.48 | 8.14 | 13.29 | 7.69 | -0.67 | |||||
Cash From Operations, 2 Yr. CAGR % | -32.75 | 21.51 | 63.39 | -20.92 | -24.19 | |||||
Capital Expenditures, 2 Yr. CAGR % | -28.82 | -19.12 | 12.89 | 23.62 | 14.17 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -15.97 | 54.05 | 56.95 | -29.02 | -25.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.63 | 53.79 | 56.68 | -28.7 | -23.35 | |||||
Dividend Per Share, 2 Yr. CAGR % | -38.76 | 59.86 | 84.84 | -46.84 | -43.69 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -6.21 | 5.56 | 20.93 | 25.91 | 10.03 | |||||
Gross Profit, 3 Yr. CAGR % | -17.97 | 7.66 | 24.87 | 10.72 | -18.14 | |||||
EBITDA, 3 Yr. CAGR % | -17.97 | 4.69 | 19.23 | 1.7 | -21.52 | |||||
EBITA, 3 Yr. CAGR % | -24.76 | 6.5 | 27.43 | 1.4 | -31.77 | |||||
EBIT, 3 Yr. CAGR % | -25.12 | 6.37 | 26.98 | -0.67 | -33.55 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -28.91 | 14.51 | 31.3 | 3.33 | -43.95 | |||||
Net Income, 3 Yr. CAGR % | -26.95 | 15.33 | 31.02 | 1.37 | -45.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | -26.55 | 10.29 | 28.35 | 1.69 | -42.06 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -26.95 | 15.33 | 31.02 | 1.37 | -45.72 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.94 | 6.06 | 20.1 | 17.38 | 9.51 | |||||
Inventory, 3 Yr. CAGR % | 1.58 | 9.25 | 27.85 | 27.77 | 22.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.32 | 5.16 | 9.83 | 11.86 | 9.96 | |||||
Total Assets, 3 Yr. CAGR % | 6.19 | 7.65 | 12.56 | 14.77 | 8.92 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.17 | 5.09 | 0.3 | 0.41 | -4.7 | |||||
Common Equity, 3 Yr. CAGR % | 3 | 5.79 | 9.29 | 9.9 | 3.43 | |||||
Cash From Operations, 3 Yr. CAGR % | -17.2 | 7.08 | 13.23 | 19.3 | -17.32 | |||||
Capital Expenditures, 3 Yr. CAGR % | -24.62 | -19.18 | -7.16 | 16.8 | 16.8 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -16.86 | 38.15 | 16.12 | 23.44 | -28.3 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -16.39 | 38.25 | 16.09 | 23.57 | -27.02 | |||||
Dividend Per Share, 3 Yr. CAGR % | -23.69 | 12.86 | 31.57 | 2.7 | -34.38 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.19 | 10.68 | 10.71 | 7.93 | 13.38 | |||||
Gross Profit, 5 Yr. CAGR % | -4.96 | 10.01 | 6.32 | -6.99 | 1.1 | |||||
EBITDA, 5 Yr. CAGR % | -5.63 | 9.67 | 3.57 | -11.83 | -2.9 | |||||
EBITA, 5 Yr. CAGR % | -9.89 | 11.69 | 5.05 | -16.76 | -7.15 | |||||
EBIT, 5 Yr. CAGR % | -10.15 | 11.62 | 4.83 | -18.03 | -8.69 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -12.49 | 17.83 | 7.47 | -18.52 | -14.34 | |||||
Net Income, 5 Yr. CAGR % | -10.16 | 20.16 | 8.64 | -18.74 | -16.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | -10.44 | 16.28 | 6.73 | -18.93 | -13.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -10.16 | 20.16 | 8.64 | -18.74 | -16.01 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.01 | 6.69 | 10.08 | 4.69 | 13.15 | |||||
Inventory, 5 Yr. CAGR % | 5.16 | 9.87 | 15 | 17.28 | 19.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.84 | 3.67 | 5.48 | 9.02 | 7.41 | |||||
Total Assets, 5 Yr. CAGR % | 5.25 | 7.85 | 10.75 | 10.01 | 9.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.71 | 4.9 | 1.24 | 0.34 | 0.15 | |||||
Common Equity, 5 Yr. CAGR % | 4.2 | 5.3 | 7 | 6.45 | 5.19 | |||||
Cash From Operations, 5 Yr. CAGR % | -7 | 15.64 | 8.67 | -5.15 | -3.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | -12.38 | -14.81 | -11.4 | -4.19 | 0.84 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.72 | 36.87 | 7.2 | 5.84 | -2.64 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.88 | 36.39 | 7.49 | 6.08 | -1.67 | |||||
Dividend Per Share, 5 Yr. CAGR % | -7.79 | 19.34 | 8.71 | -16.49 | -6.3 |
- Stock Market
- Equities
- 5183 Stock
- Financials PETRONAS Chemicals Group
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition